Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 27)

被引:69
作者
Raman, Rajiv [1 ]
Gupta, Aditi [1 ]
Krishna, Suganeswari [1 ]
Kulothungan, Vaitheeswaran [2 ]
Sharma, Tarun [1 ]
机构
[1] Sankara Nethralaya, Shri Bhagwan Mahavir Vitreoretinal Serv, Madras 600006, Tamil Nadu, India
[2] Sankara Nethralaya, Dept Prevent Ophthalmol, Madras 600006, Tamil Nadu, India
关键词
Microvascular complication; Type II Diabetes Mellitus; Newly diagnosed; NEPHROPATHY; PROGRESSION; POPULATION; NEUROPATHY; PREVENTION; PRESSURE; DESIGN; ANEMIA; TIME;
D O I
10.1016/j.jdiacomp.2012.02.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The aims of this study were to report the prevalence of various microvascular complications and to identify the various clinical and biochemical characteristics related to these complications in subjects with newly diagnosed type II diabetes. Methods: Of the 5999 subjects enumerated, 1414 subjects with diabetes (both known and newly diagnosed) were analyzed for the study. Among the diabetic subjects, 248 (17.5%) were newly diagnosed with diabetes and the remaining had history of diabetes. All subjects underwent a detailed standard evaluation to detect diabetic retinopathy (fundus photography), neuropathy (vibration pressure threshold), and nephropathy (microalbuminuria). Results: The prevalence of any form of microvascular complication was 30.2% (95% confidence interval [CI] = 24.5-35.9). The prevalence of diabetic retinopathy was 4.8%, and that of diabetic nephropathy and neuropathy was 10.5%. The risk factors for developing any form of microvascular complication were increasing age (odds ratio [OR] = 1.07, 95% CI = 1.04-1.11, P<.0001), increasing systolic blood pressure (OR = 1.03, 95% CI = 1.01-1.06, P=.001), and increasing hemoglobin (OR = 1.39, 95% CI =1.09-1.79, P=.011). The risk factors for diabetic retinopathy and diabetic nephropathy were increasing systolic blood pressure (OR= 1.06 [P=.001] for retinopathy and OR= 1.04 (P=.012] for nephropathy) and increasing hemoglobin (OR = 2.20 [P=.007] for retinopathy and OR =1.57 [P=.023] for nephropathy). The risk factor for diabetic neuropathy was increasing age (OR= 1.12, P<.0001). Conclusions: Nearly one third of the newly diagnosed type II diabetes subjects had some form of microvascular complication; nephropathy, and neuropathy being commoner than retinopathy. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 53 条
[1]   Sankara Nethralaya-Diabetic Retinopathy Epidemiolopy and Molecular Genetic Study (SN-DREAMS 1): Study design and research methodology [J].
Agarwal, S ;
Raman, R ;
Paul, PG ;
Rani, PK ;
Uthra, S ;
Gayathree, R ;
McCarty, C ;
Kumaramanickavel, G ;
Sharma, T .
OPHTHALMIC EPIDEMIOLOGY, 2005, 12 (02) :143-153
[2]  
Al-Mahroos F, 2007, ANN SAUDI MED, V27, P25, DOI 10.4103/0256-4947.51536
[3]   Retinopathy in newly diagnosed type 2 diabetes mellitus [J].
Al-Zuabi, H ;
Al-Tammar, Y ;
Al-Moataz, R ;
Al-Sabti, K ;
Wani, VB ;
Hamama, F ;
Mohammad, H ;
Al-Suwayan, MH .
MEDICAL PRINCIPLES AND PRACTICE, 2005, 14 (05) :293-296
[4]  
[Anonymous], 1989, LANCET, V1, P1113
[5]  
[Anonymous], 1999, Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation
[6]  
Bala MM, 2009, POL ARCH MED WEWN, V119, P533
[7]  
Barbosa AP, 2001, DIABETES METAB, V27, P496
[8]   Response to comment on: American Diabetes Association. Standards of medical care in diabetes-2011 (vol 34, pg e54, 2011) [J].
Wysham, C. H. ;
Kirkman, M. S. .
DIABETES CARE, 2011, 34 (08) :1887-1887
[9]   Diabetic neuropathy in elderly patients - What can be done? [J].
Belmin, J ;
Valensi, P .
DRUGS & AGING, 1996, 8 (06) :416-429
[10]   Prediction of Proliferative Diabetic Retinopathy With Hemoglobin Level [J].
Conway, Baqiyyah N. ;
Miller, Rachel G. ;
Klein, Ronald ;
Orchard, Trevor J. .
ARCHIVES OF OPHTHALMOLOGY, 2009, 127 (11) :1494-1499